NCT00817765 - Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

October 31, 2009

Conditions

HIV InfectionFungal Infection

Interventions

DRUG

Posaconazole

Posaconazole oral solution 40mg/mL; 400mg BID treatment for 10 days, including dose escalation

DRUG

Fosamprenavir

fosamprenavir tablet 700mg; 1 tablet BID for 10 days

DRUG

Ritonavir

Ritonavir 100mg capsule; 1 capsule BID for 10 days

Trial Locations (1)

Radboud University Nijmegen Medical Centre, Nijmegen